We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $12.2B
1-Year Est. Return 12.45%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+12.45%
3 Year Est. Return
+44.66%
5 Year Est. Return
+68.67%
10 Year Est. Return
+295.88%
AUM
$6.22B
AUM Growth
-$194M
Cap. Flow
-$367M
Cap. Flow %
-5.9%
Top 10 Hldgs %
16.53%
Holding
380
New
29
Increased
159
Reduced
150
Closed
10

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$18M
2
MNRO icon
Monro
MNRO
+$15.1M
3
XRAY icon
Dentsply Sirona
XRAY
+$14.8M
4
HUBB icon
Hubbell
HUBB
+$12.1M
5
NTRS icon
Northern Trust
NTRS
+$8.96M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$31.3M
2
GWW icon
W.W. Grainger
GWW
+$26.8M
3
VZ icon
Verizon
VZ
+$21.9M
4
IPGP icon
IPG Photonics
IPGP
+$18.2M
5
COHR
Coherent Inc
COHR
+$16.3M

Sector Composition

Rank Sector Weight
1 Financials 18.81%
2 Healthcare 15.97%
3 Technology 14.53%
4 Industrials 12.87%
5 Consumer Discretionary 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEN icon
326
Franklin Resources
BEN
$17B
$597K 0.01%
13,330
-22,100
-62% -$944K
TD icon
327
Toronto Dominion Bank
TD
$204B
$585K 0.01%
+11,603
New +$560K
SO icon
328
Southern Company
SO
$107B
$561K 0.01%
11,711
+2,016
+21% +$101K
IJH icon
329
iShares Core S&P Mid-Cap ETF
IJH
$122B
$557K 0.01%
16,010
+2,250
+16% +$77.7K
TGT icon
330
Target
TGT
$63.4B
$541K 0.01%
10,352
+77
+0.7% +$4.21K
MRSH
331
Marsh
MRSH
$87.8B
$540K 0.01%
6,922
CBT icon
332
Cabot Corp
CBT
$4.67B
$535K 0.01%
+10,014
New +$549K
CERN
333
DELISTED
Cerner Corp
CERN
$498K 0.01%
7,497
+2,297
+44% +$147K
REGN icon
334
Regeneron Pharmaceuticals
REGN
$70.9B
$491K 0.01%
1,000
VREX icon
335
Varex Imaging
VREX
$445M
$474K 0.01%
14,011
-2,350
-14% -$80K
TMO icon
336
Thermo Fisher Scientific
TMO
$198B
$472K 0.01%
2,708
-75
-3% -$12.6K
IWB icon
337
iShares Russell 1000 ETF
IWB
$48B
$464K 0.01%
3,432
DUK icon
338
Duke Energy
DUK
$97.5B
$458K 0.01%
5,484
+1,133
+26% +$95.2K
RDS.A
339
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$445K 0.01%
8,369
+850
+11% +$45.5K
LHX icon
340
L3Harris
LHX
$52.5B
$435K 0.01%
+3,987
New +$439K
AVGO icon
341
Broadcom
AVGO
$1.76T
$420K 0.01%
18,010
+8,000
+80% +$186K
EFA icon
342
iShares MSCI EAFE ETF
EFA
$76.5B
$416K 0.01%
+6,373
New +$412K
NOC icon
343
Northrop Grumman
NOC
$74.1B
$408K 0.01%
1,590
DD icon
344
DuPont de Nemours
DD
$18.3B
$397K 0.01%
2,486
-230
-8% -$36.5K
UL icon
345
Unilever
UL
$134B
$382K 0.01%
6,278
+112
+2% +$6.68K
CMG icon
346
Chipotle Mexican Grill
CMG
$44.2B
$369K 0.01%
44,400
-6,550
-13% -$60.8K
INGR icon
347
Ingredion
INGR
$6.47B
$358K 0.01%
3,000
-500
-14% -$59.4K
QUAL icon
348
iShares MSCI USA Quality Factor ETF
QUAL
$46.1B
$352K 0.01%
4,727
BSX icon
349
Boston Scientific
BSX
$65.4B
$333K 0.01%
+12,002
New +$319K
RCL icon
350
Royal Caribbean
RCL
$77B
$328K 0.01%
+3,000
New +$318K

Similar funds

Boston Trust Walden's Q2 2017 Portfolio in Review

As of Q2 2017, Boston Trust Walden held 380 positions worth $6.22B, down 3% from $6.42B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boston Trust Walden withdrew a net $367M in Q2 2017, closing 10 positions and reducing 150 holdings. Its most notable exit was Air Methods Corp, an estimated $15.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Boston Trust Walden opened a new position in Monro worth $12.7M.

  • Boston Trust Walden's largest Q2 2017 buy was Monro: 303,868 shares worth $12.7M.
  • Boston Trust Walden added most to Alphabet (Google) Class C in Q2 2017, an estimated $18M increase.
  • Boston Trust Walden's biggest Q2 2017 reduction was CR Bard Inc., cutting an estimated $31.3M.
  • Boston Trust Walden fully exited Air Methods Corp in Q2 2017, selling an estimated $15.4M.
  • Boston Trust Walden's ten largest holdings make up 17% of its $6.22B portfolio in Q2 2017.
  • Boston Trust Walden opened 29 new positions and closed 10 in Q2 2017.
  • Boston Trust Walden's portfolio value fell 3% quarter-over-quarter to $6.22B.

Based on Boston Trust Walden's 13F filing for Q2 2017, filed 19 Jul 2017.